Journal of Regenerative Biology and Medicine (ISSN: 2582-385X)
Journal of Regenerative Biology and Medicine is a distinguished peer-reviewed scholarly journal dedicated to advancing knowledge and innovation in the critical fields of stem cells and regenerative medicine. Based in Ottawa, CA, the journal serves as a leading source of comprehensive and reliable information for researchers worldwide. We are committed to disseminating original articles, review articles, case reports, and short communications freely, removing barriers to access and fostering collaboration within the scientific community.
Journal of Regenerative Biology and Medicine focuses on impactful topics including regenerative medicine therapies, stem cell applications, tissue engineering, gene and cell therapies, translational medicine, and tissue regeneration. Our journal strives to be at the forefront of scientific discovery, addressing critical areas such as stem cell transplantation, COVID-19 research, and the ethical and legal considerations surrounding these rapidly evolving fields. The journal’s ongoing development will be completed soon with the support of the company’s management, reflecting our commitment to continual improvement.
We aim to be a vital resource for scientists, clinicians, and industry professionals, contributing to groundbreaking advancements and ultimately improving patient outcomes. Journal of Regenerative Biology and Medicine welcomes researchers and innovators to explore the endless possibilities within stem cell research and regenerative biology. We invite the management to collaborate with us and create a customized and exclusive company showcase and product listing on our platform, allowing greater exposure and opportunities for growth.
Compare Journal of Regenerative Biology and Medicine with 3 companies in Book-and-Periodical-Publishing
| Comparison Field |
Journal of Regenerative B...Main Company |
Elrom VenturesView Profile |
MaxCyte, Inc.View Profile |
Oncimmune - An Alden...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2006 | 1999 | 2006 |
|
Company Size
|
— | 2-10 | 51-200 | 11-50 |
|
City
|
Kadima, Israel | Rockville, Maryland | Cambridge, MA | |
|
Country
|
United States | United States | ||
|
Skills & Keywords
Comparing with main company
|
15 Total Skills
Regenerative Medicine
Stem Cells
Tissue Engineering
Gene Therapy
Cell Therapy
Translational Medicine
Stem Cell Transplantation
Stemcells
Regenerative Biology
COVID-19
Cellular Therapies
Stem Cell Treatments
Cell & Organ Regeneration
Immunotherapy
Ethical & Legal Issues
|
6 Total
1 Common
5 Unique
Match
7%
Common Skills:
Stem Cells
Unique Skills:
Biomaterials
Biotechnology
Medical Devices
Pharmaceuticals
Venture Capital
|
19 Total
1 Common
18 Unique
Match
7%
Common Skills:
Cell Therapy
Unique Skills:
Biotechnology
Bispecifics
Cancer
Cancer Research
CARMA
Cell Engineering
+12
|
10 Total
10 Unique
Unique Skills:
Autoantibodies
Autoimmune Disease
Bioinformatics
Cancer
Companion diagnostics
Immuno oncology
+4
|
Other organizations in the same industry
This company is also known as